Keeping Track: Accelerated Approval Wins (Padcev+Keytruda) And Losses (Imbruvica To Shed MCL, MZL Claims)

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet's US FDA Perfomance Tracker.

Keeping Track Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers